New research shows a common skin fungus can help melanoma spread by changing cancer cell movement and energy use.

Researchers analyzed the health records of more than 33,800 U.S. veterans diagnosed with non-melanoma skin cancer and found ...

A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin cancer after five years, new data confirming its prolonged benefit show.

This wireless, battery-free wearable senses electrical differences between pigmented lesions and healthy skin, allowing for easier skin cancer screenings at home.

Several types of skincare products used to treat acne have been recalled due to a cancer risk. The products, which contain benzoyl peroxide, a common treatment for acne, were tested for elevated ...

What if the earliest signs of skin cancer could be identified sooner—before a dermatology appointment?

Receiving a diagnosis of squamous cell carcinoma (SCC) can be an overwhelming experience, but it is important to remember ...

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, pharmaceutical companies Moderna and Merck announced in five-year findings.

Adults with nonmelanoma skin cancer reported higher unadjusted levels of day-to-day mental distress, but adjusted analyses ...

No longer confined to cancer centers, skin complications of cancer therapies are now commonly encountered at the community level and require the care of a dermatologist.

By Kamal Choudhury and Mariam Sunny Jan 20 (Reuters) - Moderna and Merck said on Tuesday their experimental personalized vaccine continued to cut the risk of death or recurrence of the most deadly ...